Feeding difficulties and eating disorders in pediatric patients with cancer

Erika Damasco-Ávila1, Liliana Velasco-Hidalgo1, Marta Zapata-Tarrés1

  • 1Departmento de Oncología Pediátrica, Mexico City, Mexico.

Insights

Over 90% of pediatric cancer patients experience feeding difficulties, impacting nutrition and development. Early identification of appetite loss and feeding fear is crucial for managing malnutrition risks in these children.

Area of Science:

  • Pediatric Oncology
  • Clinical Nutrition
  • Child Psychology

Background:

  • Feeding difficulties are prevalent in children, affecting development.
  • These issues involve nutritional deficiencies impacting psychomotor, psychosocial, and physical growth.
  • This study focuses on feeding difficulties in pediatric cancer patients.

Purpose of the Study:

  • To determine the frequency of feeding difficulties and disorders in pediatric cancer patients.
  • To analyze the relationship between age and the type of feeding disorder.
  • To identify key feeding alterations associated with malnutrition in this population.

Main Methods:

  • A prospective study involving 125 children (ages 1-19) at a pediatric oncology department.
  • Feeding disorders and difficulties were diagnosed within 48 hours of admission.
  • Age-specific influences on feeding disorders were analyzed.

Main Results:

  • Over 90% of patients exhibited at least one feeding difficulty or disorder.
  • Older children (>11 years) showed more feeding resistance due to pain (fear of feeding).
  • Loss of appetite (OR: 8.8) and fear of feeding (OR: 3.14) were strongly linked to malnutrition; organic causes also posed a risk (OR: 3.1).

Conclusions:

  • Feeding difficulties are highly common in pediatric cancer patients.
  • Inadequate nutritional intake, driven by appetite loss and feeding fear, leads to undernutrition.
  • Integrating nutritional assessment is vital for comprehensive cancer patient care.
Abstract

Related Concept Videos

Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
446
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.3K